Literature DB >> 23333015

Spacer stability and prostate position variability during radiotherapy for prostate cancer applying a hydrogel to protect the rectal wall.

Michael Pinkawa1, Marc D Piroth, Richard Holy, Nuria Escobar-Corral, Mariana Caffaro, Victoria Djukic, Jens Klotz, Michael J Eble.   

Abstract

BACKGROUND AND
PURPOSE: The aim was to evaluate the spacer dimensions and prostate position variability during the course of radiotherapy for prostate cancer.
MATERIALS AND METHODS: CT scans were performed in a group of 15 patients (G1) after the 10 ml injection of a hydrogel spacer (SpaceOAR™) and 30 patients without a spacer (G2) before the beginning of treatment (CT1) and in the last treatment week, 10-12 weeks following spacer implantation (CT2). Spacer dimensions and displacements were determined and prostate displacements compared.
RESULTS: Mean volume of the hydrogel increased slightly (17%; p<0.01), in 4 of 15 patients >2 cm(3). The average displacement of the hydrogel center of mass was 0.6mm (87%≤ 2.2mm), -0.6mm (100% ≤ 2.2mm) and 1.4mm (87% ≤ 4.3mm) in the x-, y- and z-axes (not significant). The average distance between prostate and anterior rectal wall before/at the end of radiotherapy was 1.6 cm/1.5 cm, 1.2 cm/1.3 cm and 1.0 cm/1.1cm at the level of the base, middle and apex (G1). Prostate position variations were similar comparing G1 and G2, but significant systematic posterior displacements were only found in G2.
CONCLUSIONS: A stable distance between the prostate and anterior rectal wall results during the radiotherapy course after injection of the spacer before treatment planning. Larger posterior prostate displacements could be reduced.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23333015     DOI: 10.1016/j.radonc.2012.11.010

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  28 in total

1.  Current role of spacers for prostate cancer radiotherapy.

Authors:  Michael Pinkawa
Journal:  World J Clin Oncol       Date:  2015-12-10

2.  Hydrogel injection reduces rectal toxicity after radiotherapy for localized prostate cancer.

Authors:  Michael Pinkawa; Vanessa Berneking; Liane König; Dilini Frank; Marilou Bretgeld; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2016-09-08       Impact factor: 3.621

3.  Rectal ulcer associated with SpaceOAR hydrogel insertion during prostate brachytherapy.

Authors:  Amy Y M Teh; Hung-Ta Ko; Gavin Barr; Henry H Woo
Journal:  BMJ Case Rep       Date:  2014-12-22

4.  A radiopaque polymer hydrogel used as a fiducial marker in gynecologic-cancer patients receiving brachytherapy.

Authors:  Ryan J Bair; Eric Bair; Akila N Viswanathan
Journal:  Brachytherapy       Date:  2015-10-23       Impact factor: 2.362

5.  A Novel Absorbable Radiopaque Hydrogel Spacer to Separate the Head of the Pancreas and Duodenum in Radiation Therapy for Pancreatic Cancer.

Authors:  Avani D Rao; Ziwei Feng; Eun Ji Shin; Jin He; Kevin M Waters; Stephanie Coquia; Robert DeJong; Lauren M Rosati; Lin Su; Dengwang Li; Juan Jackson; Stephen Clark; Jeffrey Schultz; Danielle Hutchings; Seong-Hun Kim; Ralph H Hruban; Theodore L DeWeese; John Wong; Amol Narang; Joseph M Herman; Kai Ding
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-08-14       Impact factor: 7.038

Review 6.  A review of rectal toxicity following permanent low dose-rate prostate brachytherapy and the potential value of biodegradable rectal spacers.

Authors:  M E Schutzer; P F Orio; M C Biagioli; D A Asher; H Lomas; D Moghanaki
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-02-17       Impact factor: 5.554

Review 7.  Effectiveness of rectal displacement devices in managing prostate motion: a systematic review.

Authors:  Mahdieh Afkhami Ardekani; Hamed Ghaffari; Mahmoud Navaser; Seyed Hamid Zoljalali Moghaddam; Soheila Refahi
Journal:  Strahlenther Onkol       Date:  2020-05-22       Impact factor: 3.621

8.  Preliminary analysis of prostate positional displacement using hydrogel spacer during the course of proton therapy for prostate cancer.

Authors:  Hiroki Sato; Takahiro Kato; Tomoaki Motoyanagi; Kimihiro Takemasa; Yuki Narita; Masato Kato; Takuya Matsumoto; Sho Oyama; Hisashi Yamaguchi; Hitoshi Wada; Masao Murakami
Journal:  J Radiat Res       Date:  2021-03-10       Impact factor: 2.724

9.  Treatment planning after hydrogel injection during radiotherapy of prostate cancer.

Authors:  M Pinkawa; C Bornemann; N Escobar-Corral; M D Piroth; R Holy; M J Eble
Journal:  Strahlenther Onkol       Date:  2013-07-10       Impact factor: 3.621

10.  Dose Prediction Model for Duodenum Sparing With a Biodegradable Hydrogel Spacer for Pancreatic Cancer Radiation Therapy.

Authors:  Ziwei Feng; Avani D Rao; Zhi Cheng; Eun Ji Shin; Joseph Moore; Lin Su; Seong-Hun Kim; John Wong; Amol Narang; Joseph M Herman; Todd McNutt; Dengwang Li; Kai Ding
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-07-19       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.